Dr. Nan Schuurmans MD
Dr. Nan Schuurmans is currently the Clinical Director of the Regional Women's Health Program for the Alberta Capital Health region (greater Edmonton) and is also Clinical Professor, Department of Obstetrics & Gynaecology, University of Alberta.
Dr. Schuurmans is very active in the SOGC and was President in 1996-97. She was co-chair of the SOGC/Women's Health Task Force, 1998-2000, is a past member and chair of the Clinical Practice Obstetrics Committee, and was on the editorial board of the Society's Journal (JOGC), as well as serving on various other SOGC Committees.
Dr. Schuurmans received her medical degree with distinction from the University of Saskatchewan in 1977 and completed her residency training in Obstetrics and Gynaecology at Queen's University in 1983. She has been in active clinical practice in Edmonton since 1983 and, in addition to general obstetrics and gynaecology, runs a multidisciplinary Menopause Clinic and a Pelvic Pain Clinic. Her work in these areas has led to an interest in the interaction of hormones and mood, and in the area of sexual dysfunction.
Dr. Schuurmans' other areas of interest and expertise are promoting continuous improvement and best practice in obstetrical and gynaecologic care, innovative community health initiatives to improve prenatal and postnatal care, and exploring new methods of service delivery and physician payment to improve and maintain obstetrical care. In 1996-97, she was awarded a prestigious "Creating Healthier Communities" fellowship through The Healthcare Forum. In 2002, she was named recipient of a "Rewarding Excellence & Achievement in Capital Health" (REACH) Award in the category of Innovation, in recognition of her work in developing alternate models of care for hard-to-reach obstetrical patients. In 2004, she was the recipient of Capital Women's Health REACH award for Leadership. In 2005, Dr. Schuurmans authored the 3rd Edition of Healthy Beginnings: Your Handbook for Pregnancy and Birth.
I have the following financial relationships to disclose:
Advisory Board Member - Actavis Specialty Pharmaceuticals Co.
Advisory Board Member - Bayer HealthCare Pharmaceuticals
I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. "off-label" use of medication).